Form 4 filed by ROTHBLATT MARTINE A
ROTHBLATT MARTINE A filed this Form 4 on UNITED THERAPEUTICS Corp with 25 transaction rows and 5 holding rows, accepted by EDGAR 2026-10-05 20:53:14 UTC.
- Accession
- 0001106578-26-000156
- Filer
- CIK 1106578
- Filed
- 2026-10-05
- Accepted by EDGAR
- Ingested
- Source
- EDGAR daily index
Issuer and reporting owners
Issuer: UNITED THERAPEUTICS Corp (CIK 1082554)
- ROTHBLATT MARTINE A director, officer (Chairperson & CEO)
Rows
| Security | Date | Code | Shares | Price | Owned after | Ownership |
|---|---|---|---|---|---|---|
| Common Stock | 2026-10-02 | M exercised | +9,500 | $117.76 | 333,943 | I by Trust |
| Common Stock | 2026-10-02 | S sold | -700 | $542.0614 | 333,243 | I by Trust |
| Common Stock | 2026-10-02 | S sold | -408 | $542.8734 | 332,835 | I by Trust |
| Common Stock | 2026-10-02 | S sold | -1,032 | $544.1749 | 331,803 | I by Trust |
| Common Stock | 2026-10-02 | S sold | -1,280 | $544.8996 | 330,523 | I by Trust |
| Common Stock | 2026-10-02 | S sold | -309 | $546.7466 | 330,214 | I by Trust |
| Common Stock | 2026-10-02 | S sold | -1,171 | $547.9926 | 329,043 | I by Trust |
| Common Stock | 2026-10-02 | S sold | -1,206 | $548.8749 | 327,837 | I by Trust |
| Common Stock | 2026-10-02 | S sold | -757 | $549.5911 | 327,080 | I by Trust |
| Common Stock | 2026-10-02 | S sold | -432 | $550.9887 | 326,648 | I by Trust |
| Common Stock | 2026-10-02 | S sold | -725 | $551.8169 | 325,923 | I by Trust |
| Common Stock | 2026-10-02 | S sold | -160 | $552.8563 | 325,763 | I by Trust |
| Common Stock | 2026-10-02 | S sold | -80 | $554.3 | 325,683 | I by Trust |
| Common Stock | 2026-10-02 | S sold | -80 | $555.6043 | 325,603 | I by Trust |
| Common Stock | 2026-10-02 | S sold | -240 | $557.4315 | 325,363 | I by Trust |
| Common Stock | 2026-10-02 | S sold | -120 | $558.5967 | 325,243 | I by Trust |
| Common Stock | 2026-10-02 | S sold | -120 | $560.66 | 325,123 | I by Trust |
| Common Stock | 2026-10-02 | S sold | -40 | $562.35 | 325,083 | I by Trust |
| Common Stock | 2026-10-02 | S sold | -80 | $563.88 | 325,003 | I by Trust |
| Common Stock | 2026-10-02 | S sold | -80 | $566.58 | 324,923 | I by Trust |
| Common Stock | 2026-10-02 | S sold | -240 | $569.8973 | 324,683 | I by Trust |
| Common Stock | 2026-10-02 | S sold | -120 | $570.6969 | 324,563 | I by Trust |
| Common Stock | 2026-10-02 | S sold | -80 | $572.4369 | 324,483 | I by Trust |
| Common Stock | 2026-10-02 | S sold | -40 | $574.225 | 324,443 | I by Trust |
| Common Stock holding | 40,513 | D | ||||
| Common Stock holding | 166 | I by Spouse | ||||
| Common Stock holding | 249,108 | I by Trust | ||||
| Common Stock holding | 45,596 | I by Trust | ||||
| Common Stock holding | 8,902 | I by Trust | ||||
| Stock Option derivative | 2026-10-02 | M exercised | -9,500 | $0 | 309,410 | I by Trust |